Skip to main content
Top
Published in: World Journal of Urology 6/2019

01-06-2019 | Fertility | Topic Paper

Optimizing male fertility: oxidative stress and the use of antioxidants

Authors: Joao Paulo Cardoso, Marcello Cocuzza, Dean Elterman

Published in: World Journal of Urology | Issue 6/2019

Login to get access

Abstract

Purpose

Management of male infertility is always a difficult task, with pathophysiology and available treatments often poorly understood. The purpose of this review was to summarize current evidence regarding the use of protective agents against reactive oxygen species (ROS), such as antioxidants that may be useful in the treatment of male factor infertility.

Methods

For this publication, a search of studies concerning oxidative stress, male infertility and antioxidant therapy was performed using the search engines ScienceDirect, OVID, PubMed and MEDLINE. Articles published in languages other than English were not considered.

Results

An interest in the physiologic and pathologic effects of ROS has grown. Nevertheless, use of antioxidants is challenging, considering the balance between physiological ROS activity and detrimental oxidative stress level. Several studies have shown positive outcomes in terms of semen parameters, with others having failed to do so. Available evidence is still limited in pregnancy and live birth rates.

Conclusions

Protective agents against ROS, such as antioxidants, may have positive effects on semen parameters in some patients, although a widespread indication is still restricted by practical aspects, including unknown physiological levels of ROS and controversy regarding different concentrations and combinations of drugs.
Literature
2.
go back to reference Castagné V et al (1999) An optimal redox status for the survival of axotomized ganglion cells in the developing retina. Neuroscience 93(1):313–320CrossRefPubMed Castagné V et al (1999) An optimal redox status for the survival of axotomized ganglion cells in the developing retina. Neuroscience 93(1):313–320CrossRefPubMed
3.
go back to reference Greabu M et al (2008) Oxygen, a paradoxical element? Rom J Intern Med 46(2):125–135PubMed Greabu M et al (2008) Oxygen, a paradoxical element? Rom J Intern Med 46(2):125–135PubMed
5.
go back to reference Saleh RA, Agarwal A (2002) Oxidative stress and male infertility: from research bench to clinical practice. J Androl 23(6):737–752 Saleh RA, Agarwal A (2002) Oxidative stress and male infertility: from research bench to clinical practice. J Androl 23(6):737–752
6.
go back to reference Majzoub A, Agarwal A (2018) Systematic review of antioxidant types and doses in male infertility: benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate. Arab J Urol 16(1):113–124CrossRefPubMedPubMedCentral Majzoub A, Agarwal A (2018) Systematic review of antioxidant types and doses in male infertility: benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate. Arab J Urol 16(1):113–124CrossRefPubMedPubMedCentral
7.
go back to reference Agarwal A, Saleh RA, Bedaiwy MA (2003) Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 79(4):829–843CrossRefPubMed Agarwal A, Saleh RA, Bedaiwy MA (2003) Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 79(4):829–843CrossRefPubMed
9.
go back to reference Aitken RJ, Krausz C (2001) Oxidative stress, DNA damage and the Y chromosome. Reproduction 122(4):497–506CrossRefPubMed Aitken RJ, Krausz C (2001) Oxidative stress, DNA damage and the Y chromosome. Reproduction 122(4):497–506CrossRefPubMed
10.
go back to reference Agarwal A, Makker K, Sharma R (2008) Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol 59:2–11CrossRefPubMed Agarwal A, Makker K, Sharma R (2008) Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol 59:2–11CrossRefPubMed
11.
go back to reference Koppers AJ et al (2008) Significance of mitochondrial reactive oxygen species in the generation of oxidative stress in spermatozoa. J Clin Endocrinol Metabol 93:3199–3207CrossRef Koppers AJ et al (2008) Significance of mitochondrial reactive oxygen species in the generation of oxidative stress in spermatozoa. J Clin Endocrinol Metabol 93:3199–3207CrossRef
12.
go back to reference Ford WCL, Whittington K, Williams AC (1997) Reactive oxygen species in human sperm suspensions: production by leukocytes and the generation of NADPH to protect sperm against their effects. Int J Androl 20(Suppl 3):44–49PubMed Ford WCL, Whittington K, Williams AC (1997) Reactive oxygen species in human sperm suspensions: production by leukocytes and the generation of NADPH to protect sperm against their effects. Int J Androl 20(Suppl 3):44–49PubMed
13.
go back to reference Henkel R, Sandhu IS, Agarwal A (2019) The excessive use of antioxidant therapy: a possible cause of male infertility? Andrologia 51(1):e13162CrossRefPubMed Henkel R, Sandhu IS, Agarwal A (2019) The excessive use of antioxidant therapy: a possible cause of male infertility? Andrologia 51(1):e13162CrossRefPubMed
16.
go back to reference Greco E et al (2005) Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl 26(3):349–353CrossRef Greco E et al (2005) Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl 26(3):349–353CrossRef
17.
go back to reference Sigman M et al (2006) Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril 85(5):1409–1414CrossRefPubMed Sigman M et al (2006) Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril 85(5):1409–1414CrossRefPubMed
18.
go back to reference Rolf C et al (1999) Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 14(4):1028–1033CrossRefPubMed Rolf C et al (1999) Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 14(4):1028–1033CrossRefPubMed
19.
go back to reference Kessopoulou E et al (1995) A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 64(4):825–831CrossRefPubMed Kessopoulou E et al (1995) A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 64(4):825–831CrossRefPubMed
20.
go back to reference Moilanen J, Hovatta O, Lindroth L (1993) Vitamin E levels in seminal plasma can be elevated by oral administration of vitamin E in infertile men. Int J Androl 16(2):165–166CrossRefPubMed Moilanen J, Hovatta O, Lindroth L (1993) Vitamin E levels in seminal plasma can be elevated by oral administration of vitamin E in infertile men. Int J Androl 16(2):165–166CrossRefPubMed
22.
go back to reference Nadjarzadeh A et al (2011) Coenzyme Q 10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial. J Endocrinol Invest 34(8):e224–e228. https://doi.org/10.3275/7572 CrossRef Nadjarzadeh A et al (2011) Coenzyme Q 10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial. J Endocrinol Invest 34(8):e224–e228. https://​doi.​org/​10.​3275/​7572 CrossRef
24.
go back to reference Akmal M et al (2006) Improvement in human semen quality after oral supplementation of vitamin C. J Med Food 9(3):440–442CrossRefPubMed Akmal M et al (2006) Improvement in human semen quality after oral supplementation of vitamin C. J Med Food 9(3):440–442CrossRefPubMed
25.
go back to reference Lenzi A et al (2003) Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 79(2):292–300CrossRef Lenzi A et al (2003) Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 79(2):292–300CrossRef
26.
go back to reference Wong WY et al (2002) Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 77(3):491–498CrossRefPubMed Wong WY et al (2002) Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 77(3):491–498CrossRefPubMed
27.
go back to reference Omu AE, Dashti H, Al-Othman S (1998) Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. Eur J Obstet Gynecol Reprod Biol 79(2):179–184CrossRefPubMed Omu AE, Dashti H, Al-Othman S (1998) Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. Eur J Obstet Gynecol Reprod Biol 79(2):179–184CrossRefPubMed
Metadata
Title
Optimizing male fertility: oxidative stress and the use of antioxidants
Authors
Joao Paulo Cardoso
Marcello Cocuzza
Dean Elterman
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 6/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02656-3

Other articles of this Issue 6/2019

World Journal of Urology 6/2019 Go to the issue